Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
By
Peter Hess
13 July 2021 | 6 min read
Explore more from The Transmitter
How insights from network theory can boost interdisciplinary efforts
Communication on one interdisciplinary research team improved after the researchers turned an analysis technique used to study the brain on themselves and identified the roles people played in lab meetings.
How insights from network theory can boost interdisciplinary efforts
Communication on one interdisciplinary research team improved after the researchers turned an analysis technique used to study the brain on themselves and identified the roles people played in lab meetings.
By
Emily Singer
23 February 2026 | 0 min watch
Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again
After a clinical research career, an interlude at Apple and four months in early retirement, Raphe Bernier found joy in teaching.
Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again
After a clinical research career, an interlude at Apple and four months in early retirement, Raphe Bernier found joy in teaching.
By
Katie Moisse
20 February 2026 | 8 min read
Organoid study reveals shared brain pathways across autism-linked variants
The genetic variants initially affect brain development in unique ways, but over time they converge on common molecular pathways.
Organoid study reveals shared brain pathways across autism-linked variants
The genetic variants initially affect brain development in unique ways, but over time they converge on common molecular pathways.
By
Giorgia Guglielmi
19 February 2026 | 4 min read